ICMR reiterates concern over the use of Molnupiravir in the treatment of Kovid. India News – Times of India

New Delhi: Anti-viral drug use molanupiravir There are risks that warrant caution, health officials said, underlining…

The current COVID-19 wave in Pune may peak by the end of January or the first week of February: Official | Pune News – Times of India

Pune: In Pune district Maharashtra A senior official said that the ongoing wave of Covid-19 cases…

CoWIN slot in Maha Sarkar’s demand list for Centre, more vaccines and changes in Molnupiravir, say sources

A total of 60 lakh Kovashield and 40 lakh Covaxin doses are included in a list…

New Oxford trial to gather more data on side effects, benefits of anti-Covid pill mollupiravir: Experts

The United Kingdom is set to launch another trial to generate more data on the benefits…

Aaj Ki Baat: Full episode, January 11, 2022

Namaste and welcome to Aaj Ki Baat with Rajat Sharma, the only news show that has…

Molnupiravir will no longer be included in the COVID-19 clinical management protocol

New Delhi: A PTI report quoting official sources said that ICMR’s National Task Force for Covid-19…

Warning on Corona’s capsule: Molnupiravir should be given to the elderly but not to those of reproductive age, its unnecessary use is dangerous

Hindi News National Warning on Corona Capsules; Molnupiravir Oral Antiviral Treatment for COVID 8 minutes ago…

Mild COVID cases can be managed at home, Molnupiravir no magic medicine, says AIIMS doctor

During this Omicron-driven surge of infections, most of the Covid patients have so far shown mild…

Coronavirus treatment: do you need molanupiravir, monoclonal antibody cocktail or symptom-based treatment only if you test COVID positive? Here’s a lecturer – Times of India

We have been living with COVID for over two years now but it feels like forever.…

Aurobindo Pharma launches Covid drug Molnupiravir following advice from ICMR chief

New Delhi: Stated by ICMR chief Dr Balram Bhargava that Molnupiravir has “major safety concerns” and…